2016
Fifty Years of Expert Advice — Pharmaceutical Regulation and the Legacy of the Drug Efficacy Study
Schwartz JL. Fifty Years of Expert Advice — Pharmaceutical Regulation and the Legacy of the Drug Efficacy Study. New England Journal Of Medicine 2016, 375: 2015-2017. PMID: 27959733, DOI: 10.1056/nejmp1609763.Peer-Reviewed Original Research
2007
Lessons from the Failure of Human Papillomavirus Vaccine State Requirements
Schwartz JL, Caplan AL, Faden RR, Sugarman J. Lessons from the Failure of Human Papillomavirus Vaccine State Requirements. Clinical Pharmacology & Therapeutics 2007, 82: 760-763. PMID: 17971822, DOI: 10.1038/sj.clpt.6100397.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultChildDrug CostsDrug IndustryFemaleHealth Services AccessibilityHuman Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18HumansLobbyingMandatory ProgramsMass VaccinationMichiganPapillomavirus InfectionsPapillomavirus VaccinesParentsPersonal AutonomyPoliticsPublic PolicySchoolsSexually Transmitted Diseases, ViralState GovernmentTexasTumor Virus InfectionsUnited StatesUterine Cervical NeoplasmsConceptsHuman papillomavirusCervical cancerCervical cancer prevention effortsHPV vaccination programCancer prevention effortsPublic health issueHPV vaccinationGenital wartsVaccination programCancer preventionEffective vaccineGreater prevalenceVaccinePrevention effortsHealth issuesConservative groupGlobal healthVaccinationCancerLicensurePapillomavirusMortalityPrevalenceSubtypesWarts